Beijing Tong Ren Tang Chinese Medicine Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Wang Chi
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 1.8yrs |
Recent management updates
Recent updates
CEO
Wang Chi (49 yo)
less than a year
Tenure
Mr. Wang Chi is Executive Director and Chief Executive Officer of Beijing Tong Ren Tang Chinese Medicine Company Limited from May 10, 2024. Mr. Chi has experience in Medical and Pharmaceutical industry. Mr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | no data | no data | |
| Executive Director & Executive Deputy GM | less than a year | HK$975.00k | 0.0051% HK$ 52.1k | |
| CEO & Executive Director | less than a year | no data | no data | |
| CFO & Company Secretary | 4.1yrs | no data | no data | |
| Deputy GM & General Counsel | no data | no data | no data |
0.3yrs
Average Tenure
50yo
Average Age
Experienced Management: BJTR.F's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | less than a year | no data | no data | |
| Executive Director & Executive Deputy GM | 4.3yrs | HK$975.00k | 0.0051% HK$ 52.1k | |
| CEO & Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 6.8yrs | HK$288.00k | no data | |
| Independent Non-Executive Director | 11.2yrs | HK$288.00k | no data | |
| Non-Executive Director | 1.8yrs | no data | no data | |
| Independent Non-Executive Director | 1.3yrs | HK$240.00k | no data |
1.8yrs
Average Tenure
53yo
Average Age
Experienced Board: BJTR.F's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.